Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma

doi:10.3748/wjg.15.2258

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6284)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

729

HTML

5141

Figures (1-3)

216

Tables (1-1)

198

Sum=6284

May 14, 2009 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (140)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Gastroenterol. May 14, 2009; 15(18): 2258-2264
Published online May 14, 2009. doi: 10.3748/wjg.15.2258

Full Size Figure Download Figure

Figure 3 Cumulative survivals according to CD133 (P = 0. 774) (A), CD24 (P = 0.775) (B) and CD44 (P = 0.636) (C) expression in colorectal cancer patients (Kaplan-Meier method).

Citation: Choi D, Lee HW, Hur KY, Kim JJ, Park GS, Jang SH, Song YS, Jang KS, Paik SS. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol 2009; 15(18): 2258-2264
URL: https://www.wjgnet.com/1007-9327/full/v15/i18/2258.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2258